Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort

Affiliation auteurs!!!! Error affiliation !!!!
TitreSuperimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort
Type de publicationJournal Article
Year of Publication2016
AuteursPivot X., Pierga J-Y., Delaloge S., Fumoleau P., Bonnefoi H., Bachelot T., Jouannaud C., Bourgeois H., Rios M., Soulie P., Jacquin J.P, Lavau-Denes S., Kerbrat P., C. Mercier F, Pauporte I., Gligorov J., Curtit E., Henriques J., Paget-Bailly S., Romieu G.
JournalANNALS OF ONCOLOGY
Volume27
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1093/annonc/mdw364.1